MB, Levis & Associates’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.96K Buy
65
+1
+2% +$77 ﹤0.01% 198
2026
Q1
$4.94K Buy
+64
New +$4.98K ﹤0.01% 182
2025
Q3
Sell
-67
Closed -$5.18K 252
2025
Q2
$5.18K Sell
67
-68
-50% -$5.18K ﹤0.01% 216
2025
Q1
$10.3K Hold
135
﹤0.01% 187
2024
Q4
$10.1K Buy
135
+1
+0.7% +$76 0.01% 187
2024
Q3
$10.5K Buy
134
+1
+0.8% +$77 0.01% 190
2024
Q2
$9.97K Buy
133
+1
+0.8% +$74 0.01% 188
2024
Q1
$9.99K Hold
132
0.01% 187
2023
Q4
$10.1K Buy
132
+1
+0.8% +$73 0.01% 184
2023
Q3
$9.5K Hold
131
0.01% 195
2023
Q2
$9.86K Hold
131
0.01% 200
2023
Q1
$10.1K Buy
131
+64
+96% +$4.85K 0.01% 198
2022
Q4
$4.98K Buy
+67
New +$4.96K ﹤0.01% 209

Other funds holding BIV

MB, Levis & Associates's BIV Position: Q2 2026 in Review

MB, Levis & Associates increased its Vanguard Intermediate-Term Bond ETF (BIV) stake by 1.6% in Q2 2026, buying an estimated $77 and bringing the position to 65 shares worth $4.96K. The position accounts for ﹤0.01% of the portfolio, ranked #198.

MB, Levis & Associates first reported a position in BIV in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.5K in Q3 2024. 1,024 funds tracked by Wall St. Rank hold BIV as of Q2 2026.

  • MB, Levis & Associates held 65 shares of Vanguard Intermediate-Term Bond ETF worth $4.96K as of Q2 2026.
  • MB, Levis & Associates bought 1 Vanguard Intermediate-Term Bond ETF share in Q2 2026, an estimated $77.
  • Vanguard Intermediate-Term Bond ETF made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #198 holding.
  • MB, Levis & Associates first reported a position in Vanguard Intermediate-Term Bond ETF in Q4 2022 and has held it in 13 quarters since.
  • MB, Levis & Associates's Vanguard Intermediate-Term Bond ETF position peaked at $10.5K in Q3 2024.
  • 1,024 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.